Microvascular Changes on Head CT Indicate Cerebral Small Vessel Disease
Microvascular changes on head CT indicate cerebral small vessel disease (cSVD), which encompasses white matter hyperintensities, lacunar infarcts, enlarged perivascular spaces, and microbleeds—all markers of chronic vascular injury to the brain's small vessels that can lead to vascular cognitive impairment, stroke risk, and progressive neurological decline 1.
What You're Actually Seeing on CT
When radiologists report "microvascular changes" or "small vessel disease" on head CT, they are identifying:
- White matter hypodensities (the CT equivalent of white matter hyperintensities on MRI) - areas of chronic ischemic damage in the deep white matter
- Lacunar infarcts - small (<15mm) subcortical infarcts from occlusion of penetrating arteries
- Generalized or focal atrophy - brain volume loss from chronic vascular injury
- Chronic subcortical changes - particularly in periventricular and deep white matter regions
These findings represent the most common form of cSVD: age-associated and vascular risk factor-associated microangiopathy 1.
Clinical Significance and Risk Stratification
The severity matters significantly for prognosis:
- Mild changes (scattered white matter hypodensities): Common in aging, may be clinically silent
- Moderate to severe changes (confluent white matter disease on Fazekas scale): Associated with increased risk of cognitive impairment, gait disturbances, and future stroke 1
- Strategic location infarcts: Even small lesions in the left frontal, left temporal, left thalamus, or right parietal regions can cause significant cognitive dysfunction 1
Critical Limitation: CT Significantly Underestimates Disease Burden
Here's the major caveat: CT is far less sensitive than MRI for detecting microvascular changes 1. CT will miss:
- Small brain infarcts and covert infarcts
- Microbleeds (cerebral microhemorrhages)
- Subtle white matter lesions
- Early-stage small vessel pathology
- Cortical microinfarcts
If cognitive impairment or vascular dementia is suspected, MRI should be obtained when not contraindicated 1. MRI with core sequences (DWI, FLAIR, susceptibility-weighted imaging, T1 and T2) provides vastly superior detection of cSVD markers 1.
Underlying Pathophysiology
These changes reflect:
- Endothelial dysfunction in small penetrating arteries and arterioles 2
- Blood-brain barrier breakdown with subtle leakage 2
- Chronic hypoperfusion leading to white matter ischemia
- Microangiopathy from hypertension, diabetes, aging, and other vascular risk factors 1
What to Do Next
When microvascular changes are identified on CT:
Assess vascular risk factors aggressively: Check CBC, TSH, B12, calcium, electrolytes, creatinine, ALT, lipid panel, and HbA1c 1
Evaluate for cognitive impairment: Perform cognitive screening if not already done, as these changes are the substrate for vascular cognitive impairment 1
Consider MRI upgrade: If cognitive symptoms are present, functional decline is occurring, or clinical decision-making would change, obtain MRI for complete assessment 1
Optimize vascular risk factor control: Blood pressure management, diabetes control, lipid management, and lifestyle modifications become paramount
Monitor for progression: Serial imaging can track disease evolution, though the threshold of vascular damage required to cause clinical dysfunction varies between patients based on cognitive reserve 1
Common Pitfalls
- Dismissing findings as "normal aging": While common in older adults, moderate-to-severe changes warrant vascular risk assessment and cognitive evaluation
- Relying solely on CT: CT-detected changes represent only the tip of the iceberg; actual disease burden is likely greater
- Missing the cognitive assessment: These are not just incidental findings—they're markers of brain injury that can manifest as cognitive or functional decline
- Ignoring strategic locations: Small lesions in critical areas (frontal, temporal, thalamic) can have outsized clinical impact 1
The presence of microvascular changes on CT should trigger a systematic evaluation for vascular cognitive impairment and aggressive vascular risk factor management, recognizing that what CT shows likely underrepresents the true extent of cerebrovascular pathology 1, 2.